Funding Opportunities

Training the next generation of investigators is key to assuring the future of rare diseases research. Our 20 consortia and their affiliated patient advocacy groups offer a variety of rare disease fellowship and grant funding opportunities. Use the filters below to search these opportunities by type, application status, and research area.

BVMC YR14 Pilot Project

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To support promising junior investigators; seed new collaborations that might lead to novel research concepts or therapeutic approaches; and seed new collaborations that might lead to new grant proposals.

Sponsor: Brain Vascular Malformation Consortium (BVMC)

Eligibility Criteria: Proposals should focus on the following rare diseases and/or related outcomes in: cerebral cavernous malformation (CCM), Sturge Weber syndrome (SWS), or hereditary hemorrhagic telangiectasia (HHT). Proposals will be reviewed by the BVMC Executive Steering Committee and selected for funding based on the following criteria: clinical research potential in rare diseases, potential to enhance clinical trial readiness for any of the three BVMC diseases; thematic relationship to the aims and scope of the BVMC; scientific quality of the proposal; leverage existing BVMC (and RDCRN) resources and infrastructure, especially patient registries/databases; feasibility in projected time frame; ability to support promising junior investigators; ability to seed new collaborations that might lead to novel research concepts or therapeutic approaches; and ability to seed new collaborations that might lead to new grant proposals.

Application Due Date: 2022-01-14

Term: One - Two Years

BVMC YR14 Trainee/Clinical & Translational Investigators

Opportunity Type: Education and Career Development Opportunities

Goal: The NIH-funded Brain Vascular Malformation Consortium (BVMC, U54 NS065705) is soliciting applications to support clinical/translational investigators who focus on the study of rare neurovascular diseases, including: cerebral cavernous malformation (CCM), Sturge Weber syndrome (SWS), or hereditary hemorrhagic telangiectasia (HHT).

Sponsor: Brain Vascular Malformation Consortium (BVMC)

Eligibility Criteria: We are seeking to support advanced post-doctoral or clinical fellows, junior faculty, or established investigators who wish to develop or refocus their careers on clinical research in rare diseases. Under exceptional circumstances, we will consider applications from medical and graduate students proposing year-long projects. BVMC scholars should choose a mentor and research project aligned with one or more of the three BVMC Projects at cooperating institutions. There is wide breadth and depth of expertise spread across the BVMC that provides a rich research and mentoring environment.

Application Due Date: 2022-01-14

Term: One Year

BBDC Pilot Study

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To initiate and support collaborative research on osteogenesis imperfecta (OI).

Sponsor: Brittle Bone Disorders Consortium (BBD)

Eligibility Criteria: Both internal and external investigators are encouraged to propose and conduct pilot studies.

Letter of Intent Due Date: 2021-09-30

Application Due Date: 2021-12-01

Term: One Year

OI Foundation Michael Geisman Fellowship Grant

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The Michael Geisman Fellowship Grant program awards funding to post-doctoral trainees who are currently working on projects with clear relevance to osteogenesis imperfecta (OI), or who have projects that will enable them to develop expertise in OI research.

Sponsor: Osteogenesis Imperfecta Foundation

Eligibility Criteria: Applicant must hold an MD, DDS, DO, or PhD, and be appointed at the level of a post-doctoral trainee, or equivalent, within an academic institution. Applicant should have completed their Ph.D. or clinical training within the past five (5) years.

Application Due Date: 2021-11-30

Term: One - Two Years

2021 Biomarker Development/Validation Program

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Support the discovery and/or validation of biomarkers for ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]).

Sponsor: Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | ALS Association

Eligibility Criteria: Any individual with the requisite scientific training, irrespective of country of residence or origin. Priority will be given to those projects that are focused on developing biomarkers of disease mechanism and that might be relevant to the development of therapies.

Letter of Intent Due Date: 2021-05-07

Application Due Date: 2021-07-30

Term: One Year

Clinical Research Training Scholarship in ALS and Related Disorders

Opportunity Type: Education and Career Development Opportunities

Goal: This award aims to support young investigators engaged in clinical research focused on ALS, ALS-FTD, PLS, PMA, and HSP.

Sponsor: Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | American Brain Foundation

Eligibility Criteria: Recipient must be an AAN member interested in an academic career in neurological research who has completed residency or a PhD no more than 5 years prior to the beginning of this award (July 1, 2023). If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency.

Application Due Date: 2022-09-01

Term: Two Years

CPIC 2022 Pilot and Feasibility Program

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Projects to eliminate the disease burden associated with rare pediatric viral diseases focusing on congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal enterovirus (EV) and human parechovirus (HPeV) sepsis.

Sponsor: Congenital and Perinatal Infections Consortium (CPIC)

Eligibility Criteria: Open to full-time faculty who are early stage investigators, faculty with previous or active K-awards, and postdoctoral fellows if a faculty appointment will be made on or before September 1, 2021. Letters of intent (pre-applications) must be submitted in order to qualify. Applications are accepted by invitation only.

Letter of Intent Due Date: 2022-04-11

Application Due Date: 2022-06-01

Term: One Year

CEGIR Pilot Project

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To allow CEGIR investigators to initiate new projects relevant to eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), and/or eosinophilic colitis (EC).

Sponsor: Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Patient Advocacy Groups (American Partnership For Eosinophilic Disorders (APFED) | Campaign Urging Research for Eosinophilic Disease (CURED) | Eosinophilic Family Coalition (EFC) | The International Gastrointestinal Eosinophilic Researchers (TIGER) | National Institute of Allergy and Infectious Diseases (NIAID) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | National Center for Advancing Translational Sciences (NCATS)

Eligibility Criteria: MD, DO, PhD, or MD/PhD who is a member of CEGIR and full-time faculty at an academic institution in the USA or NIH

Letter of Intent Due Date: 2020-01-10

Application Due Date: 2020-04-15

Term: One - Two Years

CEGIR Training Award Program

Opportunity Type: Education and Career Development Opportunities

Goal: To train experts to investigate eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, physicians, patients, and professional organizations.

Sponsor: Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Patient Advocacy Groups (American Partnership For Eosinophilic Disorders (APFED) | Campaign Urging Research for Eosinophilic Disease (CURED) | Eosinophilic Family Coalition (EFC) | The International Gastrointestinal Eosinophilic Researchers (TIGER) | National Institute of Allergy and Infectious Diseases (NIAID) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | National Center for Advancing Translational Sciences (NCATS)

Eligibility Criteria: Applicants must be physicians trained in Internal Medicine, Pediatrics or Pathology with ongoing or completed subspecialty training (within 5 years of award start date) in a related field in an ACGME-accredited training program. Candidates should be US citizens, US permanent residents, or possess a valid visa to work in the US.

Application Due Date: 2016-06-15

Term: Three Years

Developmental Synaptopathies Consortium: Pilot Feasibility Core

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The objective of the pilot feasibility core (PFC) is to serve as an engine and source of funding support for translational research across these three rare brain disorders to further our understanding of biological processes and development of novel therapies. The PFC aims to support collaboration across disciplines and take advantage of key infrastructure across the consortium to drive research that enhances not only clinical understanding but also bolsters community education and family engagement, in order to accelerate development of new therapies.

Sponsor: Developmental Synaptopathies Consortium (DSC)

Eligibility Criteria: Applications will be accepted from investigators interested in research on TSC, PHTS and PMS disorders or research across these and/or related disorders.

Application Due Date: 2022-04-15

Term: One Year

PHTS Young Investigator Award Fellowship

Opportunity Type: Education and Career Development Opportunities

Goal: To support development in characterizing the developmental alterations associated with PTEN variants.

Sponsor: Developmental Synaptopathies Consortium (DSC) | PTEN Research Foundation

Eligibility Criteria: This opportunity is open to all investigators eligible to work at any of the Developmental Synaptopathies Consortium PHTS sites: Boston Children’s Hospital, Cleveland Clinic, Cincinnati Children’s Hospital, Stanford University and University of California, Los Angeles. If not located at a DSC site as above: the applicant can either identify an investigator from one of the DSC sites with complementary research interests or propose an experimental plan to be matched with the appropriate mentor by the DSC. Applicant’s institution is where the proposed work will take place.

Application Due Date: 2021-07-02

Term: Two Years

PMSF/DSC Young Investigator Fellowship

Opportunity Type: Education and Career Development Opportunities

Goal: To help characterize neuropsychiatric phenotypes in patients with Phelan-McDermid syndrome (PMS).

Sponsor: Phelan-McDermid Syndrome Foundation (PMSF) | Developmental Synaptopathies Consortium (DSC)

Eligibility Criteria: Highly qualified postdoctoral applicants with an MD, PhD, or MD/PhD, for the Phelan-McDermid Syndrome Foundation/Developmental Synaptopathies Consortium Young Investigator Fellowship. The ideal candidate has a clinical and/or research background in psychiatry, psychology, or neurology with a focus on neurodevelopmental disorders, and seeks to complement their expertise to become a leader in this growing field.

Application Due Date: 2022-01-14

Term: Two Years

TSC Young Investigator Fellowship

Opportunity Type: Education and Career Development Opportunities

Goal: The fellow will work within the NIH-funded Developmental Synaptopathies Consortium (DSC), a project within the Rare Disease Clinical Research Network (RDCRN), under the training of leaders in the field with a pre-established infrastructure for recruiting and phenotyping large numbers of patients with this rare disorder. Areas of potential research include, but are not limited to: iPSC derived neuronal modeling of TSC, characterization of the natural history of TSC, and development of endpoints for clinical trials in TSC.

Sponsor: TS Alliance | Developmental Synaptopathies Consortium (DSC)

Eligibility Criteria: MD, PhD, or MD/PhD applicants. The ideal candidate has a clinical or research background in either TSC biology or neurodevelopmental disorders and seeks to complement their expertise to become a leader in this growing field.

Application Due Date: 2022-03-15

Term: Two Years

Dystonia Coalition Career Development Program

Opportunity Type: Education and Career Development Opportunities

Goal: To facilitate career development for junior investigators interested in clinical and translational research relating to dystonia, or to provide a mechanism for more senior investigators from other fields to get involved in dystonia research.

Sponsor: Dystonia Medical Research Foundation | National Institute of Neurological Disorders and Stroke (NINDS) | Office of Rare Diseases Research (ORDR) | National Center for Advancing Translational Sciences (NCATS)

Eligibility Criteria: Applications must focus on dystonia. Applicants who are not part of the Dystonia Coalition may also apply. US citizenship and affiliation with a US institution are not required.

Application Due Date: 2021-04-15

Term: One Year

Dystonia Coalition Pilot Projects Program

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To foster the most promising clinical and translational studies of direct relevance to dystonia.

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Office of Rare Diseases Research (ORDR) | National Center for Advancing Translational Sciences (NCATS)

Eligibility Criteria: Applications must focus on clinical or translational projects with direct relevance to dystonia. The Dystonia Coalition is particularly interested in applicants focusing on projects that exploit data and/or resources already collected by the Dystonia Coalition and/or projects that encourage collaborations by involving different centers of the Dystonia Coalition, although independent projects related to dystonia are also welcome.

Application Due Date: 2021-04-15

Term: One Year

FCDGC Career Development Award

Opportunity Type: Education and Career Development Opportunities

Goal: Provides support for career development of biochemically trained professionals who have made a commitment to patient-oriented research in the Congenital Disorders of Glycosylation (CDG) and who have the potential to develop into productive preclinical investigators.

Sponsor: Frontiers in Congenital Disorders of Glycosylation (FCDGC)

Eligibility Criteria: Innovative, early-stage applications addressing key knowledge gaps that are without evidence of alternate means of independent funding are encouraged.

Application Due Date: 2021-01-01

Term: One Year

FCDGC Pilot and Feasibility Projects

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The FCDGC provides funds for projects that will exclusively focus on CDG related science and it is meant to produce preliminary data supporting areas of research that are either new in the CDG field or new to an established investigative team. We will especially focus on projects that have the potential for high-impact on CDG patient care. The scope of projects supported by this P&F award mechanism will include any step of the CDG care continuum, ranging from novel concepts in clinical management, developing novel diagnostics, as well as exploring pathomechanisms and new therapeutics (animal or human studies) in CDG. FCDGC will value proposals that are in the high risk, high impact category. The consortium also aims to form new multidisciplinary collaborations that will enhance the integration of the techniques offered at the participating institutions that will benefit multiple investigators.

Sponsor: Frontiers in Congenital Disorders of Glycosylation (FCDGC) | CDG Care

Eligibility Criteria: All basic, translational, or clinical investigators located at institutions within the United States who are eligible to apply as a Principal Investigator for NIH grants.

Application Due Date: 2021-12-15

Term: One Year

PCD & GDMCC Early Career Investigator Award

Opportunity Type: Education and Career Development Opportunities

Goal: To support promising physician-scientists and clinical investigators with a commitment to research in primary ciliary dyskinesia to develop into independent biomedical researchers.

Sponsor: Primary Ciliary Dyskinesia Foundation (PCD) | Genetic Disorders of Mucociliary Clearance Consortium (GDMCC)

Eligibility Criteria: Open to senior fellows and junior faculty intended to facilitate the transition from postdoctoral fellowship training to a career in academic medicine. Candidates must be U.S. or Canadian citizens or permanent residents and employed at an institution in the U.S. or Canada.

Application Due Date: 2021-09-01

Term: One Year

GLIA-CTN Career Development Award

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: A mentored award designed to provide "protected time" for clinically trained individuals to receive supervised training in biomedical research related to leukodystrophies. A long-term goal is to establish a Leukodystrophy Center at each award recipient’s local institution. The award supports a period of supervised research, in conjunction with career development opportunities, for physician-scientists who require additional mentored training and support during development of an innovative research project.

Sponsor: Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

Eligibility Criteria: Candidates for the award must have a doctoral degree within the health professions (e.g., MD, DO, DDS, DMD, OD, DC, PharmD) and be actively affiliated with a US-based academic and/or health care institution. Individuals with degrees in nursing research and/or practice, who are licensed to practice clinically, may be eligible. There are also certain circumstances in which individuals with a PhD may be eligible, outlined below. Innovative, early-stage applications addressing key knowledge gaps that are without evidence of alternate means of funding (i.e., “high-risk/high-yield”) are encouraged.

Application Due Date: 2023-02-20

Term: One Year

GLIA-CTN Pilot Project Award

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To generate preliminary research data needed to secure more substantial funding through traditional federal, institutional, and/or industry grant mechanisms. Recognizing the importance of creating a sustainable infrastructure for collaborative research and excellence in clinical care, the GLIA-CTN Pilot Project Award is designed to enhance clinical trial readiness in the leukodystrophies through clinical/translational research in biomarkers, or assays to assess therapeutics, or other initiatives directed towards clinical trial readiness.

Sponsor: Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

Eligibility Criteria: Candidates for the award must have a doctoral degree within the health professions (e.g., MD, DO, DDS, DMD, OD, DC, PharmD) and be actively affiliated with a US-based academic and/or health care institution. Individuals with degrees in nursing research and/or practice, who are licensed to practice clinically, may be eligible. There are also certain circumstances in which individuals with a PhD may be eligible. Innovative, early-stage applications addressing key knowledge gaps that are without evidence of alternate means of funding (i.e., “high-risk/high-yield”) are encouraged.

Application Due Date: 2023-02-20

Term: One Year

INC Diversity, Equity and Inclusion Internship Position

Opportunity Type: Other

Goal: To develop a study team member’s skill as an emerging leader in addressing disparities, underrepresentation and improving outcomes among populations that are traditionally underserved in clinical research.

Sponsor: Inherited Neuropathy Consortium (INC)

Eligibility Criteria: This program is designed for junior study team members who are planning to attend a graduate program in a clinical or clinical research-related discipline.

Application Due Date: 2021-09-03

Term: 9 Months

Inherited Neuropathy Training Fellowship

Opportunity Type: Education and Career Development Opportunities

Goal: The fellowships will offer a broad training in all aspects of clinical research in inherited neuropathies as well as an opportunity to conduct a more detailed research project of the trainee’s choice.

Sponsor: Inherited Neuropathy Consortium (INC)

Eligibility Criteria: Applicants will be expected to have completed a residency in neurology and preferably one year of a neuromuscular fellowship or equivalent. Under certain circumstances more senior applicants including those starting junior faculty positions will be considered. For applicants, an essential requirement will be the long term career aim to develop a clinical or laboratory research interest in hereditary neuropathies.

Application Due Date: 2016-02-19

Term: One - Two Years

ADVANCE Sanfilippo Funding Mechanism

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Cure Sanfilippo Foundation seeks to support research that fills critical gaps in current knowledge across basic science, clinical care, and translational therapeutics which will ultimately improve the lives of children with Sanfilippo syndrome. Scientist-clinician-patient collaborations are highly encouraged and an area of active engagement for the Foundation

Sponsor: The Cure Sanfilippo Foundation

Eligibility Criteria: All funding awards are contingent upon alignment with the goals and priorities of the Foundation and availability of resources.

Letter of Intent Due Date: 2022-08-17

Application Due Date: 2022-08-29

Term: One Year

Fellowship Award Mechanism

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The Foundation’s aim in supporting trainees is to build a pipeline of talent among early career scientists and clinicians focused on Sanfilippo syndrome from within and outside of the field of lysosomal diseases.

Sponsor: The Cure Sanfilippo Foundation

Eligibility Criteria: All funding awards are contingent upon alignment with the goals and priorities of the Foundation and availability of resources.

Application Due Date: 2022-08-29

Term: Two Years

Fellowships of the LDN

Opportunity Type: Education and Career Development Opportunities

Goal: One-year fellowship for a post-doctoral level researcher with an interest in a career in lysosomal diseases.

Sponsor: Lysosomal Disease Network (LDN)

Eligibility Criteria: Applicants should be a recent post-doctoral professional with an interest in clinical research of lysosomal diseases This could include physicians with training in relevant disciplines, as well as pharmacists, psychologists, or other suitably qualified professionals (i.e., MD, PhD, MD-PhD, DO, PsyD, DDS, PharmD, DNP, etc.).

Application Due Date: 2021-06-15

Term: One Year

Lysosomal Storage Diseases Fellowship

Opportunity Type: Education and Career Development Opportunities

Goal: To provide extensive training in the recognition, natural history, diagnosis, testing strategies, treatment, and management of lysosomal storage diseases (LSDs) and the co-morbidities.

Sponsor: University of California, Irvine School of Medicine | Lysosomal Disease Network (LDN)

Eligibility Criteria: Candidates may include physicians or genetic counselors with an interest in metabolic disorder. Counselors may be board-certified or eligible for certification in Genetic counseling

Application Due Date: 2022-02-01

Term: One Year

National MPS Society Pilot Program: Cycle I

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Seeking applications addressing ML II/III, MPS I, MPS II, MPS III, MPS IVA, or MPS VI, alone or as part of a comparative approach involving other syndromes, as well as physiological systems with commonality between individual MPS and ML disorders.

Sponsor: National MPS Society

Eligibility Criteria: Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Principal Investigator (PI) is invited to apply. A PI must be institutionally eligible to apply for, be awarded, and administer an extramural research grant.

Letter of Intent Due Date: 2022-03-15

Application Due Date: 2022-05-15

Term: One - Two Years

National MPS Society Pilot Program: Cycle II

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Seeking applications addressing ML II/III, MPS I, MPS II, MPS III, MPS IVA, or MPS VI, alone or as part of a comparative approach involving other syndromes, as well as physiological systems with commonality between individual MPS and ML disorders.

Sponsor: National MPS Society

Eligibility Criteria: Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Principal Investigator (PI) is invited to apply. A PI must be institutionally eligible to apply for, be awarded, and administer an extramural research grant.

Letter of Intent Due Date: 2022-03-15

Application Due Date: 2022-05-15

Term: One - Two Years

National MPS Society Pilot Program: Cycle III

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Seeking applications addressing ML II/III, MPS I, MPS II, MPS III, MPS IVA, or MPS VI, alone or as part of a comparative approach involving other syndromes, as well as physiological systems with commonality between individual MPS and ML disorders.

Sponsor: National MPS Society

Eligibility Criteria: Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Principal Investigator (PI) is invited to apply. A PI must be institutionally eligible to apply for, be awarded, and administer an extramural research grant.

Letter of Intent Due Date: 2022-03-15

Application Due Date: 2022-05-15

Term: One - Two Years

NTSAD Research Initiative Program: Request for Proposals

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: NTSAD’s Research Initiative Program is soliciting proposals for innovative research projects that involve basic research, translational studies or clinical studies in the following diseases: Tay-Sachs, Canavan, GM1, and Sandhoff diseases.

Sponsor: National Tay-Sachs & Allied Diseases Association (NTSAD)

Eligibility Criteria: Projects that focus on understanding the pathophysiology and the role of inflammation in TaySachs, Canavan, GM1, and Sandhoff diseases, or the process of myelination and how it is affected by disease are of particular interest. Applicants are strongly encouraged to submit proposals for clinical tools that support future trials across the severity spectrum of any given indication. This may include developing severity scales for disease staging, translational biomarkers with clinical utility, or measurable and clinically meaningful efficacy endpoints for clinical trials.

Letter of Intent Due Date: 2022-02-18

Application Due Date: 2022-04-01

Term: One - Two Years

Pilot Funding Mechanism

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Cure Sanfilippo Foundation seeks to support research that fills critical gaps in current knowledge across basic science, clinical care, and translational therapeutics which will ultimately improve the lives of children with Sanfilippo syndrome.

Sponsor: The Cure Sanfilippo Foundation

Eligibility Criteria: All funding awards are contingent upon alignment with the goals and priorities of the Foundation and availability of resources.

Letter of Intent Due Date: 2022-08-17

Application Due Date: 2022-08-29

Term: Year 2 funding will be dependent upon progress dem

Pilot Projects of the LDN

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: These awards promote innovative research at the forefront of new therapies/technologies for lysosomal disease.

Sponsor: Lysosomal Disease Network (LDN)

Eligibility Criteria: Must be able to receive this funding through grant/contract from the University of Minnesota through an academic institution or medical center that is actively receiving other funding from the U.S. National Institutes of Health.

Application Due Date: 2021-06-15

Term: One Year

Myasthenia Gravis Network (MGNet) Scholar Program

Opportunity Type: Education and Career Development Opportunities

Goal: The MGNet Scholar Program provides individualized training and mentorship in one of two tracks, Clinical Research or Biomarker Development Research.

Sponsor: Myasthenia Gravis Rare Disease Network (MGNet)

Eligibility Criteria: Applicants must have a M.D. (or equivalent) or Ph.D. Clinical fellows, post-doctoral fellows, or junior faculty are eligible. Applicants must identify a primary mentor with appropriate content expertise and experience mentoring young investigators. Candidates should be U.S. citizens, U.S. permanent residents, or non-U.S. citizens with a valid visa to work in the U.S. MGNet Scholars do not have be at a MGNet site.

Application Due Date: 2022-10-01

Term: Two years

Pilot Grant Program for Myasthenia Gravis

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Pilot studies must be designed to access the resources of MGNet and focused on clinical research, including fulfilling the definition of clinical research and exclusion of animal studies.

Sponsor: Myasthenia Gravis Rare Disease Network (MGNet) | Myasthenia Gravis Foundation of America | Conquer MG

Eligibility Criteria: The PI must hold an MD, PhD, MD/PhD, RN or more advanced, PharmD, DDS, DVM, or equivalent and be a faculty member at an academic institution.

Application Due Date: 2022-10-01

Term: Two Years

NephCure Grant Program

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To support investigator-initiated studies that employ NEPTUNE resources to advance clinical and translational research in glomerular disease.

Sponsor: NephCure Kidney International (NephCure)

Eligibility Criteria: NEPTUNE investigators and their collaborators OR scientists presently unaffiliated with NEPTUNE. Applicants are required to leverage the resources provided by NEPTUNE (infrastructure, accumulated human subjects and their associated data and materials) by bringing additional resources to conducting proposed investigations.

Letter of Intent Due Date: 2021-12-10

Application Due Date: 2022-03-29

Term: One Year

NEPTUNE Career Development Fellowship

Opportunity Type: Education and Career Development Opportunities

Goal: To support advanced post-doctoral and junior faculty trainees, or established investigators interested in redirecting their investigative focus, who are preparing to become independent investigators in clinical and translational research in human glomerular disease.

Sponsor: Nephrotic Syndrome Study Network (NEPTUNE)

Eligibility Criteria: Clinical fellows (MD, MD/PhD, or equivalent degrees) who have completed their clinical training in nephrology or pathology or a subspecialty relevant to the study of glomerular disease in humans, advanced PhD post-doctoral fellows with training in biostatistics or translational research who seek advanced training in clinical research in human glomerular disease, junior faculty with training similar to that noted above, established investigators interested in refocusing their investigative path to include studies of glomerular disease in humans.

Application Due Date: 2022-02-03

Term: One Year

NPKUA Call for Research Proposals

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The NPKUA is seeking proposals that will help us meet the above strategic goals as well as to close existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects.

Sponsor: National PKU Alliance

Eligibility Criteria: Eligible applicants must have a Ph.D., M.D., or equivalent degrees and currently hold a full-time position at any level (post-doctoral, research scientist, assistant/associate/full professor, etc.) at an established academic/research institution. Applicants will be considered from both the United States and internationally.

Application Due Date: 2022-05-01

Term: One Year with Potential of Renewal

NPKUA Development/Validation of Function-Based Neurocognitive Testing Tools

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The NPKUA is seeking proposals that will help us meet the above strategic goals as well as to close existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects.

Sponsor: National PKU Alliance

Eligibility Criteria: Eligible applicants must have a Ph.D., M.D., or equivalent degrees and currently hold a full-time position at any level (post-doctoral, research scientist, assistant/associate/full professor, etc.) at an established academic/research institution.

Application Due Date: 2022-05-01

Term: One Year with Potential of Renewal

NPKUA Post-Doctoral Fellowship

Opportunity Type: Education and Career Development Opportunities

Goal: The NPKUA is seeking proposals that will help us meet the above strategic goals, promote and encourage young investigators into PKU-related research, to close the existing gaps in the knowledge and science of PKU, and to further support existing PKU-related projects.

Sponsor: National PKU Alliance

Eligibility Criteria: Eligible applicants must have a Ph.D., M.D., or equivalent degrees and have an opportunity to hold a full-time fellowship position at an established academic/research institution. Both United States and international academic institutions will be considered.

Application Due Date: 2022-05-01

Term: Two Years

PHEFREE Pilot and Feasibility Projects

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The objective of the PHEFREE pilot/feasibility program is to provide funding for studies of innovative ideas or hypotheses which, if successful, could lead to improvement in the understanding, prevention, diagnosis and/or treatment of hyperphenylalaninemia, biopterin defects and related conditions.

Sponsor: Phenylalanine Families and Researchers Exploring Evidence (PHEFREE)

Eligibility Criteria: M.D., Ph.D., or M.D./Ph.D. investigators are eligible to apply.

Application Due Date: 2023-01-06

Term: One Year

PHEFREE Research Fellowship

Opportunity Type: Education and Career Development Opportunities

Goal: The primary mission of this program is to train and attract new investigators to research on hyperphenylalaninemia, biopterin defects and related conditions that is directly relevant to improvement in patient care, treatment and quality of life.

Sponsor: Phenylalanine Families and Researchers Exploring Evidence (PHEFREE)

Eligibility Criteria: Graduate and postgraduate trainees, postdoctoral fellows, and junior faculty within 10 years from the completion of their degree/residency/clinical training are eligible.

Application Due Date: 2023-01-06

Term: One Year

PC Pilot and Feasibility Program

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: For trainees, postdocs, and junior faculty who want to pursue new directions in porphyria research.

Sponsor: Porphyria Consortium (PC)

Eligibility Criteria: Priority will be given to junior investigators and postdocs. Established Investigators starting a new line of research in heme and porphyria may also apply.

Application Due Date: 2022-07-31

Term: One Year

IDF White Paper Challenge

Opportunity Type: Other

Goal: To address the persistent challenge to achieve earlier diagnosis and expanding and diversifying our community.

Sponsor: Immune Deficiency Foundation (IDF)

Eligibility Criteria: All individuals, institutions, schools, and researchers.

Application Due Date: 2022-02-28

Term: One Year

Immune Deficiency Foundation 2022 Research Grant

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To support well-defined research projects that have a specified benefit for improving the treatment, health, disease management or diagnosis of persons with primary immunodeficiency. Consideration will also be given to studies that contribute to the body of medical knowledge in primary immunodeficiency.

Sponsor: Immune Deficiency Foundation (IDF)

Eligibility Criteria: The program is open to applicants currently based in the U.S. and will consist of one-year grants. Investigators (MD, PhD, RN) with an interest in or currently pursuing a career in primary immunodeficiency diseases and research are particularly encouraged to apply.

Application Due Date: 2022-02-28

Term: One Year

PIDTC Pilot/Demonstration Project Program

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Promote discovery in the field resulting in new peer-reviewed publications and to generate preliminary data necessary to fuel the design and implementation of clinical trials with robust mechanistic studies

Sponsor: Primary Immune Deficiency Treatment Consortium

Eligibility Criteria: Must have an appointment as an independent faculty member, eligible to apply for NIH grant funding, at an eligible PIDTC center. Junior faculty (within 5 years of their appointment) are encouraged to apply.

Letter of Intent Due Date: 2022-03-18

Application Due Date: 2022-05-02

Term: One Year

PIDTC Research Training Grant in Primary Immunodeficiencies

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: The purpose of the award is to encourage research in primary immunodeficiencies, particularly related to treatment by, transplantation, gene therapy, or best available medical management.

Sponsor: Primary Immune Deficiency Treatment Consortium (PIDTC)

Eligibility Criteria: Trainees or Junior Faculty with two years or less as a faculty member. Prior recipients can compete to receive one additional year of continuous funding with a progress report documenting that headway has been made on the research topic as long as they are still eligible by trainee status. Underrepresented minority applicants specifically encouraged to apply.

Application Due Date: 2022-04-25

Term: One Year

SCID Angels for Life Research Grant

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To improve long-term outcomes and/or reduce treatment related long-term complications, thereby improving quality of life post treatment and to find innovative approaches aimed at improving the diagnosis, the treatment, or maintaining the treatment continuity of Severe Combined Immune Deficiency (SCID) patients, within marginalized communities.

Sponsor: SCID Angels for Life Foundation

Eligibility Criteria: Eligible applicants should hold a Ph.D. or M.D degree. Applicants should be full-time permanent faculty members or post-doctoral fellows with a degree in fields related to SCID including, Immunology, Hematology, Cell Biology, Medicine, Biochemistry, Translational Research, or a similar field, at a research institute within the United States or Canada.

Application Due Date: 2021-12-15

Term: One Year

UCDC Pilot/Feasibility Program

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: To provide funding for pilot projects or feasibility projects that take maximum advantage of new clinical research opportunities in UCDs.

Sponsor: Urea Cycle Disorders Consortium (UCDC)

Eligibility Criteria: Anyone conducting UCD research is eligible. Must have a UCDC sponsor or we can help identify one, if needed. Only one application can be submitted from each UCDC site/institution.

Letter of Intent Due Date: 2021-01-22

Application Due Date: 2021-03-15

Term: One Year

UCDC Research Fellowship in Urea Cycle Disorders

Opportunity Type: Education and Career Development Opportunities

Goal: To train and attract new investigators who will conduct research in urea cycle disorders (UCDs) that contribute to a better understanding of UCDs and help improve the treatment and quality of life for individuals with UCDs.

Sponsor: Urea Cycle Disorders Consortium (UCDC)

Eligibility Criteria: Graduate and postgraduate trainees, postdoctoral fellows, and junior faculty within 10 years from the completion of their degree/residency/clinical training are eligible.

Application Due Date: 2022-06-06

Term: One Year